{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:53:45Z","timestamp":1786118025683,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1097\/01.all.0000246621.34247.fa","type":"journal-article","created":{"date-parts":[[2006,11,6]],"date-time":"2006-11-06T05:59:09Z","timestamp":1162792749000},"page":"455-460","source":"Crossref","is-referenced-by-count":15,"title":["Peptide immunotherapy for allergic diseases using a rice-based edible vaccine"],"prefix":"10.1097","volume":"6","author":[{"given":"Takachika","family":"Hiroi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Takaiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000084256","article-title":"Increasing prevalence of Japanese cedar pollinosis: a meta-regression analysis","volume":"136","author":"Kaneko","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3950\/jibiinkoka.105.751","article-title":"Medical consultation dynamics in Japanese cedar pollinosis patients at an office building clinic in central Tokyo","volume":"105","author":"Nishihata","year":"2002","journal-title":"Nippon Jibiinkoka Gakkai Kaiho"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0091-6749(90)90157-Y","article-title":"J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule","volume":"85","author":"Hejjaoui","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1398-9995.1995.tb01170.x","article-title":"Grass pollen immunotherapy: efficacy and safety during a 4-year follow-up study","volume":"50","author":"Walker","year":"1995","journal-title":"Allergy"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4049\/jimmunol.125.2.587","article-title":"Purification and characterization of the major allergen from Dermatophagoides pteronyssinus-antigen P1","volume":"125","author":"Chapman","year":"1980","journal-title":"J Immunol"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0091-6749(98)70271-4","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper","volume":"102","author":"Bousquet","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ni0802-715","article-title":"Asthma: an epidemic of dysregulated immunity","volume":"3","author":"Umetsu","year":"2002","journal-title":"Nat Immunol"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0006-2952(99)00226-9","article-title":"Molecular consequences of human mast cell activation following immunoglobulin E-high-affinity immunoglobulin E receptor (IgE-FcepsilonRI) interaction","volume":"58","author":"Reischl","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2567.2003.01576.x","article-title":"Production of interleukin-13 by human dendritic cells after stimulation with protein allergens is a key factor for induction of T helper 2 cytokines and is associated with activation of signal transducer and activator of transcription-6","volume":"108","author":"Bellinghausen","year":"2003","journal-title":"Immunology"},{"key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.4049\/jimmunol.170.9.4457","article-title":"IL-6 production by pulmonary dendritic cells impedes Th1 immune responses","volume":"170","author":"Dodge","year":"2003","journal-title":"J Immunol"},{"key":"R11-10-20210128","first-page":"199","article-title":"Allergen avoidance in house dust mite sensitive adult asthma","volume":"58","author":"Walshaw","year":"1986","journal-title":"Q J Med"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0091-6749(96)70150-1","article-title":"Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis","volume":"98","author":"Foresi","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0091-6749(95)70090-0","article-title":"Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial","volume":"95","author":"Grant","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"R14-10-20210128","first-page":"10","article-title":"Situation and trends of hyposensitisation treatment (author's translation)","volume":"25","author":"Jager","year":"1979","journal-title":"Allerg Immunol"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1385\/CRIAI:27:2:147","article-title":"Fatalities following allergen immunotherapy","volume":"27","author":"Borchers","year":"2004","journal-title":"Clin Rev Allergy Immunol"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1348-0421.1984.tb00679.x","article-title":"Mucosal immunoregulation: environmental lipopolysaccharide and GALT T lymphocytes regulate the IgA response","volume":"28","author":"McGhee","year":"1984","journal-title":"Microbiol Immunol"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4615-3410-5_13","article-title":"Induction of T helper cells and cytokines for mucosal IgA responses","volume":"327","author":"Xu-Amano","year":"1992","journal-title":"Adv Exp Med Biol"},{"key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/000163501750541174","article-title":"A revisit of mucosal IgA immunity and oral tolerance","volume":"59","author":"Fujihashi","year":"2001","journal-title":"Acta Odontol Scand"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1440-1711.1998.00716.x","article-title":"Oral tolerance as therapy for experimental autoimmune encephalomyelitis and multiple sclerosis: demonstration of T cell anergy","volume":"76","author":"Jewell","year":"1998","journal-title":"Immunol Cell Biol"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1196\/annals.1309.033","article-title":"Regulation of autoreactive T cell function by oral tolerance to self-antigens","volume":"1029","author":"Whitacre","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0952-7915(98)80079-4","article-title":"T cell immunity to oral allergens","volume":"10","author":"MacDonald","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1286-4579(01)01456-3","article-title":"Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells","volume":"3","author":"Weiner","year":"2001","journal-title":"Microbes Infect"},{"key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri1370","article-title":"Therapeutic potential of oral tolerance","volume":"4","author":"Mayer","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/clin.1996.0102","article-title":"Peptide therapy for treatment of allergic diseases","volume":"80","author":"Wallner","year":"1996","journal-title":"Clin Immunol Immunopathol"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000024403","article-title":"Peptide-mediated immune responses in specific immunotherapy","volume":"122","author":"Haselden","year":"2000","journal-title":"Ant Arch Allergy Immunol"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nm1226","article-title":"Peptide-based therapeutic vaccines for allergic and autoimmune diseases","volume":"11","author":"Larche","year":"2005","journal-title":"Nature Med"},{"key":"R27-10-20210128","doi-asserted-by":"crossref","first-page":"17525","DOI":"10.1073\/pnas.0503428102","article-title":"A rice-based edible vaccine expressing multiple epitopes induces oral tolerance for inhibition of Th2-mediated IgE responses","volume":"102","author":"Takagi","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R28-10-20210128","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0091-6749(98)70334-3","article-title":"Oral administration of a dominant T-cell determinant peptide inhibits allergen-specific Th1 and Th2 cell response in Cry j 2-primed mice","volume":"102","author":"Hirahara","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2567.2002.01534.x","article-title":"Three T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen antigens, retain their immunogenicity and tolerogenicity in a linked peptide","volume":"107","author":"Yoshitomi","year":"2002","journal-title":"Immunology"},{"key":"R30-10-20210128","doi-asserted-by":"crossref","first-page":"448","DOI":"10.4049\/jimmunol.161.1.448","article-title":"T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for management of Japanese cedar pollinosis","volume":"161","author":"Sone","year":"1998","journal-title":"J Immunol"},{"key":"R31-10-20210128","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1067\/mai.2001.115481","article-title":"Preclinical evaluation of an immunotherapeutic peptide comprising 7 T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen allergens","volume":"108","author":"Hirahara","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"R32-10-20210128","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1467-7652.2005.00143.x","article-title":"Oral immunotherapy against a pollen allergy using a seed-based peptide vaccine","volume":"3","author":"Takagi","year":"2005","journal-title":"Plant Biotech J"},{"key":"R33-10-20210128","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1360-1385(01)01922-7","article-title":"Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants","volume":"6","author":"Daniell","year":"2001","journal-title":"Trends Plant Sci"},{"key":"R34-10-20210128","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0958-1669(03)00026-0","article-title":"Plant cell factories and mucosal vaccines","volume":"14","author":"Walmsley","year":"2003","journal-title":"Curr Opin Biotechnol"},{"key":"R35-10-20210128","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0264-410X(02)00603-5","article-title":"Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives","volume":"21","author":"Sala","year":"2003","journal-title":"Vaccine"},{"key":"R36-10-20210128","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.copbio.2005.01.005","article-title":"Sowing the seeds of success: pharmaceutical proteins from plants","volume":"16","author":"Stoger","year":"2005","journal-title":"Curr Opin Biotechnol"},{"key":"R37-10-20210128","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1467-7652.2004.00055.x","article-title":"Tissue specific expression and quantitative potential evaluate of seed storage component gene promoters in transgenic rice","volume":"2","author":"Qu","year":"2004","journal-title":"Plant Biotech J"},{"key":"R38-10-20210128","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1046\/j.1467-7652.2003.00038.x","article-title":"Foreign gene products can be enhanced by introduction into low storage protein mutants","volume":"1","author":"Tada","year":"2003","journal-title":"Plant Biotech J"},{"key":"R39-10-20210128","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.tibtech.2003.10.002","article-title":"Molecular farming in plants: host systems and expression technology","volume":"21","author":"Twyman","year":"2003","journal-title":"Trends Biotechnol"}],"container-title":["Current Opinion in Allergy &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.all.0000246621.34247.fa","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:04:26Z","timestamp":1786028666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130832-200612000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.all.0000246621.34247.fa","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}